Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Céline Ducournau
Observed name:
Ducournau, Céline
Institutions:
Université de Tours,
Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement,
Infectiologie et santé publique
Observed institutions:
Université de Tours,
Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement,
Infectiologie et santé publique,
Institut National de la Recherche Agronomique
ORCID:
0000-0002-0920-2392
Observed ORCID:
0000-0002-0920-2392
OpenAlex ID:
A5058764161
Porous nanoparticles as delivery system of complex antigens for an effective vaccine against acute and chronic Toxoplasma gondii infection
2015
·
Isabelle Dimier-Poisson
, Rodolphe Carpentier
, et al.
·
Biomaterials
·
71
Effective Nanoparticle-Based Nasal Vaccine Against Latent and Congenital Toxoplasmosis in Sheep
2020
·
Céline Ducournau
, Nathalie Moiré
, et al.
·
Frontiers in Immunology
·
66
PDF
Mic1-3 Knockout Toxoplasma gondii is a good candidate for a vaccine against T. gondii -induced abortion in sheep
2010
·
Marie-Noëlle Mévélec
, Céline Ducournau
, et al.
·
Veterinary Research
·
53
PDF
Functional activation of T cells by dendritic cells and macrophages exposed to the intracellular parasite Neospora caninum
2011
·
Sarah Dion
, Stéphanie Germon
, et al.
·
International Journal for Parasitology
·
36
Protein delivery by porous cationic maltodextrin-based nanoparticles into nasal mucosal cells: Comparison with cationic or anionic nanoparticles
2018
·
Minh Quan Lê
, Rodolphe Carpentier
, et al.
·
International Journal of Pharmaceutics X
·
34
PDF
Synthetic Parasites: A Successful Mucosal Nanoparticle Vaccine Against Toxoplasma Congenital Infection in Mice
2017
·
Céline Ducournau
, Thi T L Nguyen
, et al.
·
Future Microbiology
·
32
PDF
Residence time and uptake of porous and cationic maltodextrin-based nanoparticles in the nasal mucosa: Comparison with anionic and cationic nanoparticles
2018
·
Minh Quan Le
, Rodolphe Carpentier
, et al.
·
International Journal of Pharmaceutics
·
30
Neospora caninum: a new class of biopharmaceuticals in the therapeutic arsenal against cancer
2020
·
Louis Lantier
, Agathe Poupée-Beaugé
, et al.
·
Journal for ImmunoTherapy of Cancer
·
20
PDF
Vaccination of squirrel monkeys (Saimiri spp.) with nanoparticle-based Toxoplasma gondii antigens: new hope for captive susceptible species
2023
·
Céline Ducournau
, Pauline Cantin
, et al.
·
International Journal for Parasitology
·
13
PDF
Babesia divergens glycosylphosphatidylinositols modulate blood coagulation and induce Th2-biased cytokine profiles in antigen presenting cells
2019
·
Françoise Debierre-Grockiego
, Terry K. Smith
, et al.
·
Biochimie
·
13
PDF
Nasal administration of recombinant Neospora caninum secreting IL-15/IL-15Rα inhibits metastatic melanoma development in lung
2023
·
Arthur Battistoni
, Louis Lantier
, et al.
·
Journal for ImmunoTherapy of Cancer
·
11
PDF
In vitro cellular responses to Neospora caninum glycosylphosphatidylinositols depend on the host origin of antigen presenting cells
2019
·
Héloïse Débare
, Jörg Schmidt
, et al.
·
Cytokine
·
11
PDF
Neospora caninum glycosylphosphatidylinositols used as adjuvants modulate cellular immune responses induced in vitro by a nanoparticle-based vaccine
2021
·
Héloïse Débare
, Nathalie Moiré
, et al.
·
Cytokine
·
10
PDF
Intranasal spike and nucleoprotein fusion protein-based vaccine provides cross-protection and reduced transmission against SARS-CoV-2 variants
2025
·
Zineb Lakhrif
, Agathe Poupée-Beaugé
, et al.
·
npj Vaccines
·
8
PDF
Neospora caninum as delivery vehicle for anti-PD-L1 scFv-Fc: A novel approach for cancer immunotherapy
2025
·
Clément Riviere
, Muna Aljieli
, et al.
·
Molecular Therapy Oncology
·
3
Abstract 1712: Neospora caninum: An immunotherapeutic protozoan against cancer
2021
·
Louis Lantier
, Agathe Poupée-Beaugé
, et al.
·
Cancer Research
·
3
846 Neospora caninum – an immunotherapeutic protozoan against solid cancers
2020
·
Louis Lantier
, Agathe Poupee-Beauge
, et al.
·
Journal for ImmunoTherapy of Cancer
·
3
PDF
Serum-free bioproduction of an oncolytic protozoan for immunotherapy
2026
·
Lakhrif, Zineb
, Moiré, Nathalie
, et al.
·
HAL
Bioproduction of Neospora caninum: a proof-of- concept towards a scalable serum-free process
2026
·
Zineb Lakhrif
, Nathalie Moiré
, et al.
·
Research Square
PDF
Caractérisation de l'altération du métabolisme des cellules tumorales par l'infection du protozoaire Neospora caninum
2026
·
Galerne, Alice
, Bourgeais, Jérôme
, et al.
·
HAL
Overcoming Bioproduction Locks for Neospora caninum in Immuno-Oncology
2025
·
Moiré, Nathalie
, Ducournau, Céline
, et al.
·
HAL
Étude de la toxicité tissulaire du paracétamol et mesure télémétrique de la variation de température lors d'une toxoplasmose chez la souris
2019
·
Riou, Mickael
, Guionnière, Marion
, et al.
·
HAL
Des imidazopyridazines ciblant la TgCDPK1 diminuent fortement l’infection par Toxoplasma gondii dans un modèle murin de toxoplasmose congénitale
2019
·
Débare, Héloïse
, Baron, Firmin
, et al.
·
HAL
WITHDRAWN: Babesia divergens glycosylphosphatidylinositols modulate blood coagulation and induce Th2-biased cytokine profiles in antigen presenting cells
2019
·
Françoise Debierre-Grockiego
, Terry K. Smith
, et al.
·
Biochimie Open
Toxoplasma gondii : un espoir de vaccin ?
2018
·
Ducournau, Céline
, Roucheray, Stéphanie
, et al.
·
HAL
Show more works
View as search
Works count:
43
Citation count:
417
H-index:
11
I10-index:
13
Year
Topic
Type